What is the typical clinical and laboratory presentation of hemophagocytic syndrome?

Hemophagocytic Syndrome Presentation

Hemophagocytic syndrome presents with persistent high fever (100% of cases), cytopenias affecting multiple cell lines (93-95%), splenomegaly (81-95%), and markedly elevated ferritin levels (typically 7,000-10,000 mg/L, sometimes >100,000 mg/L), often accompanied by hepatomegaly and characteristic laboratory derangements including hypertriglyceridemia and hypofibrinogenemia 1.

Core Clinical Features

The clinical presentation is dominated by:

• Fever: Universal finding (100% of cases), typically persistent and high-grade (>38.4°C) 1, 2, 3
• Organomegaly: Splenomegaly occurs in 81-95% of cases, with hepatomegaly present in approximately 97% 1, 3, 4
• Lymphadenopathy: Present in 26-66% of patients 1, 3, 4

Laboratory Hallmarks

The most sensitive and specific laboratory findings include:

Hematologic Abnormalities

• Cytopenias affecting ≥2 cell lineages (93-95% of cases):
  • Hemoglobin <90 g/L
  • Platelets <100 × 10⁹/L
  • Neutrophils <1.0 × 10⁹/L 1

Biochemical Markers

• Hyperferritinemia (93-100% of cases): Levels of 7,000-10,000 mg/L are characteristic; values >10,000 mg/L are >90% sensitive and specific in children, though less specific in adults 1, 2
• Hypertriglyceridemia (54-60%): Fasting triglycerides ≥3.0 mmol/L (≥265 mg/dL) 1, 2, 3
• Hypofibrinogenemia (61-67%): Fibrinogen ≤1.5 g/L 1, 2, 3

Specialized Testing

• Elevated soluble CD25 (sCD25): ≥2,400 U/mL (100% when tested); this has superior diagnostic accuracy compared to ferritin (AUC 0.90 vs 0.78) 1
• Low or absent NK cell activity: 95% of cases when tested 1, 3
• Hemophagocytosis: Found in bone marrow, spleen, or lymph nodes in 78-93% of cases 1, 2, 3

Additional Clinical Manifestations

Other common features that support the diagnosis:

• Hepatic dysfunction (100% in some series): Elevated transaminases (AST ≥30 U/L), hypoalbuminemia 1, 4
• Coagulation abnormalities (52%): Including DIC in severe cases 3, 4
• CNS involvement (15-20%): Cerebromeningeal symptoms, CSF pleocytosis, elevated CSF protein 1, 3, 4
• Respiratory symptoms (36-54%): Pulmonary infiltrates, infection 3, 4
• Skin manifestations (12-13%): Rash, edema 1, 4
• Other findings: Jaundice (27%), hydrops of serous cavities (27%), hyponatremia, elevated LDH, low HDL/elevated VLDL 1, 4

Diagnostic Framework

The HLH-2004 criteria require 5 of 8 findings:

1. Fever
2. Splenomegaly
3. Cytopenias (≥2 lineages)
4. Hypertriglyceridemia and/or hypofibrinogenemia
5. Hemophagocytosis in bone marrow/spleen/lymph nodes
6. Low/absent NK cell activity
7. Ferritin ≥500 mg/L
8. Soluble CD25 ≥2,400 U/mL 1

Critical Pitfalls

Important caveats in recognition:

• Hemophagocytosis may be absent initially: Serial bone marrow examinations over time may be necessary; absence does not exclude diagnosis 1, 4
• Hyperferritinemia is less specific in adults: While ferritin >10,000 mg/L strongly suggests HLH, integration of multiple clinical features is required 1
• Overlap with underlying conditions: In malignancy-associated HLH, features may overlap substantially with the neoplasm itself, making identification challenging 5
• Treatment may be initiated before meeting full criteria: When clinical suspicion is high and organ dysfunction is present, therapy should not be delayed 1

Underlying Triggers

Always search for precipitating factors:

• Infections (most common, 63%): Particularly EBV, CMV, and other herpes viruses 1, 3
• Malignancies (especially in adults): T-cell/NK-cell lymphomas (35%), B-cell lymphomas (32%), leukemias, with mean age at onset 49 years 1
• Autoimmune/autoinflammatory diseases 1, 3

The diagnosis requires high clinical suspicion in any patient with persistent fever, unexplained cytopenias, and disproportionate inflammatory response, particularly with rapid clinical deterioration 6.